Thomas E. Shelton
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 2%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Oncology 8
- CAR-T cell therapy research 7
- Cancer Immunotherapy and Biomarkers 2
-
- Immunotherapy and Immune Responses 4
- Immune Cell Function and Interaction 2
- Galectins and Cancer Biology 1
- T-cell and B-cell Immunology 1
- Co-authors
- Steven A. Rosenberg (7 shared papers)Mark E. Dudley (3 shared papers)John R. Wunderlich (2 shared papers)Jos Even (1 shared paper)Paul F. Robbins (5 shared papers)Michelle M. Langhan (3 shared papers)Zhili Zheng (2 shared papers)Stephanie L. Goff (3 shared papers)
- Journals
- Journal of Immunotherapy (3 papers)Nature Medicine (1 paper)Clinical Cancer Research (1 paper)Archives of Biochemistry and Biophysics (1 paper)Human Gene Therapy (1 paper)
- Partner nations
- United StatesMalaysia
In The Last Decade
Thomas E. Shelton
8 papers receiving 1.7k citations
Thomas E. Shelton's Hit Papers
Peers
Comparison fields: 5 of 60
- Oncology 1.3k
- Immunology 1.0k
- Genetics 256
- Biotechnology 53
- Molecular Biology 352
Countries citing papers authored by Thomas E. Shelton
This map shows the geographic impact of Thomas E. Shelton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Shelton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Shelton more than expected).
Fields of papers citing papers by Thomas E. Shelton
This network shows the impact of papers produced by Thomas E. Shelton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Shelton. The network helps show where Thomas E. Shelton may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas E. Shelton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer Hit paper breakdown → | 2018 | 567 |
| 2 | Generation of Tumor-Infiltrating Lymphocyte Cultures for Use in Adoptive Transfer Therapy for Melanoma Patients Hit paper breakdown → | 2003 | 556 |
| 3 | 2008 | 220 | |
| 4 | 2008 | 118 | |
| 5 | 2019 | 110 | |
| 6 | 2021 | 76 | |
| 7 | 2018 | 48 | |
| 8 | 2000 | 8 |
About Thomas E. Shelton
Thomas E. Shelton is a scholar working on Oncology, Immunology, Molecular Biology, Pulmonary and Respiratory Medicine and Genetics, having authored 8 papers that have together received 1.7k indexed citations. Recurring topics across this work include CAR-T cell therapy research (7 papers), Immunotherapy and Immune Responses (4 papers), Cancer Immunotherapy and Biomarkers (2 papers), Immune Cell Function and Interaction (2 papers), Cancer Genomics and Diagnostics (1 paper), Galectins and Cancer Biology (1 paper), T-cell and B-cell Immunology (1 paper) and Protein Tyrosine Phosphatases (1 paper). The work is most often cited by research in Oncology (1.3k citations), Immunology (1.0k citations), Genetics (256 citations), Biotechnology (53 citations) and Molecular Biology (352 citations). Thomas E. Shelton has collaborated with scholars based in United States and Malaysia. Frequent co-authors include Steven A. Rosenberg, Mark E. Dudley, John R. Wunderlich, Jos Even, Paul F. Robbins, Michelle M. Langhan, Zhili Zheng, Stephanie L. Goff, Anna Pasetto and Jared J. Gartner. Their work appears in journals such as Journal of Immunotherapy, Nature Medicine, Clinical Cancer Research, Archives of Biochemistry and Biophysics and Human Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.